Lots to like in that article. The agreement with PDX comes...

Lots to like in that article.

• The agreement with PDX comes following MedAdvisor’s success last year in attracting leading healthcare company EBOS onto its register, with EBOS taking a 14.1% holding in the company for $9.5m.

• The additional funding has also provided MedAdvisor with a strong cash balance and according the Company, it has plenty of cash to fund the integration in the US and to continue its expansion efforts domestically.

• MedAdvisor is also targeting expansion in the UK and has an expert on the ground there to evaluate the best market entry strategy.

• This follows the news last week that MedAdvisor will provide digital communication channels for Zest, a subsidiary of EBOS and the two businesses are already working together to implement their first program.

• MedAdvisor is also eyeing expansion into the hospital market. Zest and MedAdvisor expect to collaborate on hospital programs in the near future, alongside hospital pharmacy chain and EBOS subsidiary, HPS.

• Since listing on the ASX in December 2017, MedAdvisor has increased its revenue by over 50% every half year period. In 1H FY18 the Company reported $3.25m of revenue, more than doubling its 1H FY17 revenue.

I need to correct the last point. MedAdvisor listed in December 2015, not 2017.

And I also need to repeat the last point - since listing, every half year period MedAdvisor has increased revenue by over 50%.